Ethics of controlled human infection to address COVID-19
Open Access
- 22 May 2020
- journal article
- editorial
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 368 (6493), 832-834
- https://doi.org/10.1126/science.abc1076
Abstract
High social value is fundamental to justifying these studiesThis publication has 19 references indexed in Scilit:
- Ethical Criteria for Human Challenge Studies in Infectious Diseases: Table 1.Public Health Ethics, 2015
- Risks of phase I research with healthy participants: A systematic reviewClinical Trials, 2015
- Improving understanding in the research informed consent process: a systematic review of 54 interventions tested in randomized control trialsBMC Medical Ethics, 2013
- Incidence of death and potentially life-threatening near-miss events in living donor hepatic lobectomy: A world-wide surveyLiver Transplantation, 2012
- Limits on risks for healthy volunteers in biomedical researchTheoretical Medicine and Bioethics, 2011
- A Framework for Risk-Benefit Evaluations in Biomedical ResearchKennedy Institute of Ethics Journal, 2011
- More than the money: A review of the literature examining healthy volunteer motivationsContemporary Clinical Trials, 2011
- Limits to research risksJournal of Medical Ethics, 2009
- Safety and Clinical Outcome of Experimental Challenge of Human Volunteers withPlasmodium falciparum–Infected Mosquitoes: An UpdateThe Journal of Infectious Diseases, 2007
- A Report of the Vancouver Forum on the Care of the Live Organ Donor: Lung, Liver, Pancreas, and Intestine Data and Medical GuidelinesTransplantation, 2006